using standard 24-or 48-hour recordings. [8] [9] [10] [11] However, patient-triggered event recorders are limited in two aspects. First, PAF episodes are frequently asymptomatic and, thus, remain undetected, because patients do not use the patienttriggering function. Second, it has been found that two thirds of the patients, especially the most at risk, the elderly, are inconsistent in their use of patient-triggered devices, even when symptomatic. 12 The aim of this study was to establish the frequency of PAF episodes in a selected population of patients suffering from recurrent palpitations but without any significant arrhythmias on a previous 24-hour Holter monitoring. For that purpose, a new device was used that combines continuous automatic electrocardiographic (ECG) event analysis and storage with prolonged monitoring duration. 13 
Patients and Methods Patient Population
The study investigated a cohort of 65 (45 men, 20 women; mean age 63 6 8 years) consecutive patients complaining of recurrent transient episodes of palpitations that had remained undiagnosed after a standard 24-hour ECG Holter monitoring.
These patients were extracted from a population of 140 patients complaining of palpitations and referred by their cardiologist during a 6-month period to the authors' Holter reference center, which represents about 10% of the patients referred by out hospital practitioners for arrhythmias evaluation during that period. Of the 140 patients, 36 had a diagnosis established by standard Holter recording: sick sinus syndrome (n 5 1), atrial tachycardia (n 5 6), PAF (n 5 9), and isolated premature supraventricular or ventricular beats (n 5 20). Of the 104 remaining patients, only 65 long-term recordings were accepted by the cardiologists or by the patients.
Among these 65 patients, symptoms were prolonged in 20 of them and were poorly tolerated in 5. Twenty-six patients were suffering from chronic cardiovascular diseases: hypertension (n 5 18), stable coronary artery disease (n 5 7), and mitral valve regurgitation (n 5 1). Eight had noncardiovascular disease: hyperthyroidism (n 5 2), diabetes mellitus (n 5 4), and chronic obstructive pulmonary disease (n 5 2).
Standard Initial 24-Hour Holter Monitoring
Standard three-lead Holter digital recorders were used to acquire the initial ECG data (Novacor, Rueil-Malmaison, France). The mean duration of the recordings was 23.1 6 1.2 hours (range 21-24 hours). All recordings were scanned through a DuoHolter (Novacor, Rueil-Malmaison, France) and analyzed using the interactive method.
Continuous Automatic Long-Term Cardiac Event Monitoring
Such analyses were performed by an event recorder, R-Test Evolution (RTE) (Novacor, RueilMalmaison, France), placed on the patients using two electrodes: the first electrode was placed on the sternum and a cable linking the device to the second electrode was placed at the apex position of the heart, which resulted in a lead close to a CM5 configuration. The RTE event recorder performs a continuous ECG analysis combined with an automatic storage of abnormal events detected in a 20-minute solid-state memory with an autonomy of up to 7 days. In addition, the patient is given the possibility to trigger a recording for a user-programmed amount of memory. Both types of recordings, automatic and patient-triggered, are based on a loop memory. The RTE is programmed to recognize ten categories of arrhythmic events and one category of ischemic events. The algorithm of arrhythmia analysis is based first on detection of a QRS prematurity or delay then, and only when this first condition is fulfilled, on QRS width. Without the prematurity or delay trigger, the RTE does not perform an arrhythmia analysis. There are six categories of premature events, the degree of prematurity of which is user-defined: (1) narrow single premature beats, (2) wide single premature beats, (3) 2-5 consecutive narrow premature beats, (4) 2-5 consecutive wide premature beats, (5) 6 or more consecutive narrow premature beats, and (6) 6 or more consecutive wide premature beats. Other arrhythmic events are absolute pauses, the duration of which is user-defined; relative pauses, of which the percentage of shortening is user-defined; and bradycardia, the rate of which is also user-defined. The last category of recorded events is ST-segment abnormality; the threshold values for the depth and the slope of the ST-segment depression are user-defined. In addition, a heart rate trend covering the whole recording period is systematically memorized.
The patients were instructed to report any clinical abnormality which would have occured during the recording. They were taught to note the description and the true occurrence of any clinical symptom.
Events Considered in the Analysis
Only sustained ($ 30 s) paroxysmal supraventricular tachycardic events (PAF and PSVT) were considered for this analysis. PSVT ROCHE, ET AL.
was defined as a tachycardia characterized by a heart rate $ 120 beats/min and lasting at least 30 seconds, with normal QRS morphology. PAF was defined as fine oscillations in the baseline ECG (fibrillatory waves) associated with an irregular ventricular response ratio and lasting at least 30 seconds. The 30-second limit of sustained paroxysmal events was based on the fact that this duration is generally admitted at the ventricular level as a criteria for sustained events. For an event of any length, sinus rhythm was considered restored after five consecutive sinus beats had been observed. Both events, PAF and PSVT, were classified as symptomatic or asymptomatic; events were considered as symptomatic if there was a temporal correspondence between the symptoms described in the patient logbook and the occurrence of PAF or PSVT in the recording.
Also, the RR trend recorded over the full monitoring period is of help in separating sustained PSVT from PAF. PSVT presents with a sudden rise in heart rate but the trend line remains thin. Conversely, the sudden acceleration of PAF episodes is associated to a important thickening of the trend line, due to the large variations in RR interval lengths that remain plotted on the trend.
Statistical Analysis
Statistical analysis were performed using Statview 4.5 from SAS (Cary, NC, USA). Comparisons between continuous variables were made using a Student's t-test for unpaired data. Comparisons between discrete variables were made using a chi-square test. The respective yields of the patient-triggered and the automatic modes of the RTE were compared using Kaplan-Meier cumulated survival analysis.
Results

Standard 24-Hour Holter Monitoring
All patients were free of PAF or sustained PSVT episodes on the initial 24-hour Holter recording, which was one of the inclusion criteria.
The number of isolated supraventricular beats on the initial 24-hour recordings was unrelated with the absence or presence of sustained supraventricular tachycardic events identified later using RTE (mean 6 SD number of isolated supraventricular beats: 24 6 30/hour vs 28 6 87/hour, respectively; P 5 NS).
Continuous Automatic Event Recorder
Arrhythmias will be described in terms of episodes of arrhythmias and of patients with arrhythmias. The mean 6 SD recording duration was 77 6 36 hours (range 24-144 hours). Among the 65 patients, 52 (80%) had sustained supraventricular arrhythmias: 20 (31%) presented with PAF episodes, 39 (60%) PSVT episodes, and 7 (9%) patients had both arrhythmias.
PAF
A total of 37 episodes of PAF were detected in 20 patients; these episodes were distributed as follows: 1 single episode in 10 patients; two episodes in 5 patients; 3 episodes in 4 patients; and 4 episodes in 1 patient (Fig. 1) . The exact duration of PAF episodes was unknown in 11 of the 37 episodes either because the episode began before the hook up of the device (n 5 6), or because it ended after its removal (n 5 5). The mean 6 SD duration of the remaining 26 episodes was 7 hours 50 minutes 6 8 hours 45 minutes (range 45 minutes to 28 hours).
Among the 37 episodes of PAF diagnosed, only 12 (32%) of them were contemporary with symptoms. Symptomatic PAF episodes were significantly shorter than asymptomatic ones (mean 6 SD, 4 hours 50 minutes 6 4 hours vs 10 hours 30 minutes 6 16 hours 30 minutes, respectively; P , 0.05).
The mean 6 SD time interval between the hookup of the RTE and the beginning of the first PAF episode was 16 hours 30 minutes 6 21 hours (range 0-77 hours).
When considering patients, 10 (50%) of the 20 patients with PAF or PAF plus PSVT never experienced symptoms during PAF episodes; similarly 7 (54%) of the 13 patients presenting only with PAF episodes were asymptomatic.
The mean 6 SD duration of PAF in the 13 PAF only patients was significantly longer than the duration of PAF episodes in the 7 patients presenting with both PAF and PSVT (10 hours 40 minutes 6 8 hours 39 minutes vs 2 hours 30 minutes 6 2 hours 14 minutes; P , 0.01).
PSVT
A total of 134 episodes of PSVT were observed in 39 (60%) patients. These episodes were distributed as follows: 1 episode in 3 patients, 2 episodes in 8 patients, 3 episodes in 8 patients, 4 episodes in 13 patients, 5 episodes in 4 patients, 6 episodes in 2 patients, and 7 episodes in 1 patient (Fig. 2) . The exact duration of PSVT was unknown in one episode, because it began before the hookup of the event recorder. The mean 6 SD duration of the remaining 133 episodes was 32 6 136 minutes (range 3 minutes to 24 hours).
Among the 134 episodes of PSVT detected, most of them, 105 (78%), were contemporary with symptoms. The duration of symptomatic and asymptomatic PSVT episodes were not different (mean 6 SD: 38 6 154 vs 14 6 13 minutes, respectively; P 5 NS). The time interval between the hookup of the RTE and the beginning of the first PSVT episode was 29 hours 32 minutes 6 21 hours 46 minutes (range 2-76 hours).
Only 5 (16%) of the 32 patients with PSVT were asymptomatic, and all 7 patients with both supraventricular arrythmias had at least one episode of symptomatic PSVT.
The duration of PSVT in PSVT only patients was not significantly different from the duration of PSVT episodes in the seven patients presenting with PSVT and PAF (36 minutes 6 2 hours 28 minutes vs 14 minutes 6 18 minutes; P 5 NS).
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Figure 2. Occurrence of episodes of paroxysmal supraventricular tachycardia (PSVT) during the recording time using the R-Test Evolution. The white lines illustrate recording duration for each of the 39 patients presenting PSVT episodes. The duration of the PSVT episodes are drawn in orange for symptomatic episodes and in yellow for asymptomatic ones.
Figure 1. Occurrence of episodes of paroxysmal atrial fibrillation (PAF) during the recording time using the R-Test Evolution. The white lines illustrate recording duration for each of the 20 patients presenting PAF episodes. The duration of the episodes of PAF are drawn in orange for symptomatic episodes and in yellow for asymptomatic ones.
PAF and PSVT
Five of the seven patients with both types of arrhythmias described symptoms during them but, only during their PSVT episodes in two of them. The order of appearance and of recurrence of the type of arrythmia seemed to occur at random. A significant difference in symptomatology was found between the two types of arrhythmias as 11 (54%) of the 20 patients demonstrating PAF experienced no symptom during these episodes while 34 (87%) of the 39 patients with PSVT were symptomatic (P . 0.002).
Other Arrhythmias
Only one symptomatic nonsustained ventricular tachycardia was recorded in one patient presenting with hypertrophic cardiomyopathy.
Estimated Yield of Repeated 24-Hour Holter Recordings
On the whole, automatic continuous event recording of a mean duration of 77 hours provided a plausible explanation for palpitations in 53 (81.5%) of the 65 patients, including the one with ventricular tachycardia.
When considering only the first 24-hour period of each RTE recording, a simultaneous 24-hour Holter recording which, thus, would have been the second 24-hour standard Holter recording for the 52 patients with PAF, PSVT, or both, would still have remained negative in 23 patients because of a later onset of their arrhythmias: 2 (15%) of 13 PAF only patients, 20 (63%) of 32 PSVT only patients, and 1 (14%) of 7 patients with both types of arrhythmias. The remaining 29 patients include the 7 patients whose arrhythmias began before hook up of the device (six PAF and one PSVT). Thus, in 23 (44%) patients with PAF or PSVT, a diagnosis would have been missed by a second separate 24-hour Holter recording but was revealed by the RTE.
The whole recording duration of RTE monitoring in patients presenting PAF only was equivalent to 34 periods of 24-hour standard Holter recording. Among these 34 periods, 9 (27%) of them were entirely free of arrhythmic events (Fig.  1) . For PSVT only patients, there were 39 (39%) out of 100 equivalent of consecutive 24-hour periods (Fig. 2 ) free of events, while patients presenting with both types of arrhythmias (first seven patients, Figs 1 and 2 ), had 10 (39%) out of 26 equivalent of 24-hour periods free of events.
Estimated Yield of Standard Patient-Triggered Event Recorders
If the number of patients who were symptomatic are extrapolated from their arrhythmias during continuous automatic event recording, 12 (23%) of the 52 patients would not have called during these periods of recording. This figure would have varied according to the type of arrhythmia, with 7 (54%) of 13 noncalling for PAF only patients, 5 (16%) of 32 noncalling for PSVT only patients, and 0 (0%) of 7 noncalling for patients having both types of arrhythmia.
The yield of the detection of PAF episodes using the automatic mode would thus have been significantly higher than that of the patient-triggered mode (P , 0.0001, Fig. 3 ) on this relatively short recording duration. In particular, the steep increase in the cumulative percent of PAF detection obtained by means of the automatic mode would drastically contrast with the slow increase expected with the classic patient-triggered mode.
Discussion
In a population of patients still complaining of palpitations after one negative standard 24-hour Holter recording, long-term automatic continuous cardiac event monitoring revealed numerous and prolonged episodes of PAF or PSVT in 80% of them, most of which were asymptomatic. A second standard 24-hour Holter monitoring would have left 44% of the patients with such arrhythmias undiagnosed and a classic patient-triggered event recorder 13%. It is true that in four patients, PAF or PSVT were still present at the time of the removal of the device and, thus, could have been diagnosed by a standard ECG performed at that time. However, it is unclear if such a diagnosis could have been established had the event recorder not been placed. The temporal and causal relation between atrial fibrillation and stroke is well established 2, 5, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] and available data converge to support the prescription of preventive long-term full anticoagulation in PAF patients. However, the automatic mode of the RTE clearly confirmed the frequent lack of symptomatology in PAF. In addition, the automatic mode of the RTE clearly revealed that a lack of symptomatology was much more frequent than previously thought in PAF, which raises new questions about the relation between the frequency and the duration of PAF episodes and cerebral embolic events. In that perspective, these limited data open new frontiers in enabling such a relation to be established, provided that a significant number of patients be studied and that a long enough clinical follow-up be performed.
The benefits of a long duration of recording have already been demonstrated by a prolonged use of standard Holter, on a continuous or on a discontinuous basis. Extrapolating data from 5 weekly repeated 24-hour Holter monitoring, asymptomatic PAF episodes were described to occur more than 12 times as often as symptomatic ones. 6, 7 However, such a standard Holter technique cannot be applied for time periods as long as with the RTE because of the induced discomfort for the patient. Conversely, the RTE presents as an ultracompact device and bears the convenient possibility of unweaving it, for example, during washing. This makes it a good choice for longterm automatic monitoring.
A disadvantage of the event recorder presented here lies in the lack of full recording storage. This makes incomplete the analysis and may eventually sometimes limit the strength of arrhythmia interpretation, particularly of short episodes. However, the present study clearly underlines the improved yield of long-term, automatic monitoring associating a good tolerance, a high sensitivity, and a confortable use during the active daily life.
In the present study, automaticity of the event recorders appeared as important as, or even more important than, recording duration. This parameter is of particular interest when considering that more than two thirds of the most concerned population, the elderly, are inconsistent in their use of nonautomatic event recorders, when a voluntary participation of the patient is requested to activate a record. 12 Inability to freeze tracings contemporarily with a symptomatic event has also been shown to reach 10% in implantable loop recorders. 24 The observed high percentage of asymptomatic PAF episodes should convince one towards the choice of an automatic device. However, whether automatic event recorders should replace standard 24-hour Holter to document arrhythmias in patients suffering from palpitations cannot be answered by this study, since the authors focused on a selected population with a negative standard Holter.
Knowledge of the statistical distribution of PAF episodes could allow one to optimize recording duration, which could be shorter than the presently 3 weeks proposed for patient-triggered event recorders. Nevertheless, based on the results, it is suggested that monitoring periods using automatic cardiac event recorders should not be shorter than at least 72 hours.
On the whole, automatic event recorders appear to be a powerful tool for the internist, the cardiologist, and the neurologist. The findings also suggest that epidemiological studies using such devices could allow a better description of the natural course of atrial fibrillation and of its clinical consequences, and more particularly so in the population suffering from PAF.
